Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04771897
Title A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (KONQUER)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications

brain stem glioma

high grade glioma

Therapies

BXQ-350

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.